Recipharm has announced the completion of a new analytical laboratory at its facility in Bengaluru, India.
The new 370 m2 area is fully cGMP compliant and is equipped with technology and instruments to cater for the rising demand from customers for the company’s stand-alone Recipharm Analytical Solutions, states the company.
“It’s great to be able to announce the inauguration of our new analytical laboratory under Recipharm Analytical Solutions. Despite all the challenges the pandemic has presented, our team has worked diligently to complete the project and ensure the laboratory is operational, on time,” says Ramesh Jagadeesan, Ph.D, Assistant Vice President. “We’re confident the new laboratory will bolster our ability to support our customers and meet their method development, validation and stability studies requirements while maintaining the quality services they’re accustomed to from Recipharm.”
Recipharm has also appointed Mr. Manivel Thangapragasam as Associate Director to lead the new laboratory. Manivel brings 21 years of experience in the field of analytical development and stability studies.
“I’m delighted to join the Recipharm team. Recipharm provides high quality analytical programmes and flexible capacity to customers when they need it. Given the speed the market is moving, it is clear that the demand for such services is on the rise,” says Thangapragasam.
The new lab has been in full operation since August 1 2021.